Clinical Trial: Rollover study for participants who have been treated with and are continuing to benefit from opnurasib as a single agent or in combination with other study treatments (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Rollover study for participants who have been treated with and are continuing to benefit from opnurasib as a single agent or in combination with other study treatments'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129840

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=330011

Published by HT Digital Content Services with permission from Health Daily Digest....